• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: Prospective cohort study

tetano

Editor, Senior Moderator
PLoS One


. 2023 Jan 20;18(1):e0280567.
doi: 10.1371/journal.pone.0280567. eCollection 2023.
Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: Prospective cohort study


Carlos Roberto Ribeiro Carvalho[SUP] 1 [/SUP], Celina Almeida Lamas[SUP] 1 [/SUP], Rodrigo Caruso Chate[SUP] 2 [/SUP], João Marcos Salge[SUP] 1 [/SUP], Marcio Valente Yamada Sawamura[SUP] 2 [/SUP], André L P de Albuquerque[SUP] 1 [/SUP], Carlos Toufen Junior[SUP] 1 [/SUP], Daniel Mario Lima[SUP] 3 [/SUP], Michelle Louvaes Garcia[SUP] 1 [/SUP], Paula Gobi Scudeller[SUP] 1 [/SUP], Cesar Higa Nomura[SUP] 2 [/SUP], Marco Antonio Gutierrez[SUP] 3 [/SUP], Bruno Guedes Baldi[SUP] 1 [/SUP]; HCFMUSP Covid-19 Study Group



Affiliations

Abstract

Background: Coronavirus disease (COVID-19) survivors exhibit multisystemic alterations after hospitalization. Little is known about long-term imaging and pulmonary function of hospitalized patients intensive care unit (ICU) who survive COVID-19. We aimed to investigate long-term consequences of COVID-19 on the respiratory system of patients discharged from hospital ICU and identify risk factors associated with chest computed tomography (CT) lesion severity.
Methods: A prospective cohort study of COVID-19 patients admitted to a tertiary hospital ICU in Brazil (March-August/2020), and followed-up six-twelve months after hospital admission. Initial assessment included: modified Medical Research Council dyspnea scale, SpO2 evaluation, forced vital capacity, and chest X-Ray. Patients with alterations in at least one of these examinations were eligible for CT and pulmonary function tests (PFTs) approximately 16 months after hospital admission. Primary outcome: CT lesion severity (fibrotic-like or non-fibrotic-like). Baseline clinical variables were used to build a machine learning model (ML) to predict the severity of CT lesion.
Results: In total, 326 patients (72%) were eligible for CT and PFTs. COVID-19 CT lesions were identified in 81.8% of patients, and half of them showed mild restrictive lung impairment and impaired lung diffusion capacity. Patients with COVID-19 CT findings were stratified into two categories of lesion severity: non-fibrotic-like (50.8%-ground-glass opacities/reticulations) and fibrotic-like (49.2%-traction bronchiectasis/architectural distortion). No association between CT feature severity and altered lung diffusion or functional restrictive/obstructive patterns was found. The ML detected that male sex, ICU and invasive mechanic ventilation (IMV) period, tracheostomy and vasoactive drug need during hospitalization were predictors of CT lesion severity(sensitivity,0.78±0.02;specificity,0.79±0. 01;F1-score,0.78±0.02;positive predictive rate,0.78±0.02; accuracy,0.78±0.02; and area under the curve,0.83±0.01).
Conclusion: ICU hospitalization due to COVID-19 led to respiratory system alterations six-twelve months after hospital admission. Male sex and critical disease acute phase, characterized by a longer ICU and IMV period, and need for tracheostomy and vasoactive drugs, were risk factors for severe CT lesions six-twelve months after hospital admission.
 
Back
Top Bottom